14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Experimental Lung Inflammation in 3 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Liu, T | 1 |
| Duan, JX | 1 |
| Li, P | 1 |
| Sun, GY | 1 |
| Liu, YP | 1 |
| Zhang, J | 1 |
| Dong, L | 1 |
| Lee, KSS | 1 |
| Hammock, BD | 1 |
| Jiang, JX | 1 |
| Guan, CX | 1 |
| Morin, C | 1 |
| Sirois, M | 1 |
| Echavé, V | 1 |
| Albadine, R | 1 |
| Rousseau, E | 1 |
| Planagumà, A | 1 |
| Pfeffer, MA | 1 |
| Rubin, G | 1 |
| Croze, R | 1 |
| Uddin, M | 1 |
| Serhan, CN | 1 |
| Levy, BD | 1 |
3 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Experimental Lung Inflammation
| Article | Year |
|---|---|
Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Epoxide Hydrolase | 2017 |
17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.
Topics: 8,11,14-Eicosatrienoic Acid; Anti-Inflammatory Agents; Arachidonic Acids; Bronchi; Calcium; Cyclooxy | 2010 |
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Disease; Animals; Anticholesteremic Agents; Cell Line; Disease Mo | 2010 |